Current Environment: Production

Medical Services

Specialties

Programs & Services

Languages

  • English

Education

Graduate School

Johns Hopkins University School of Medicine

2017, Baltimore, MD

Medical School

Johns Hopkins University School of Medicine

2017, Baltimore, MD

Internship

Pediatrics

Boston Combined Residency Program (BCRP)

2019, Boston, MA

Residency

Pediatric Neurology

Boston Children's Hospital

2022, Boston, MA

Fellowship

Neurogenetics

Boston Children's Hospital

2024, Boston, MA

Certifications

  • American Board of Psychiatry and Neurology (Child and Adolescent Neurology)

Professional History

Dr. Mo is a board-certified Child Neurologist with special expertise in autism spectrum disorder and neurogenetic diseases. In her clinical practice, Dr. Mo evaluates patients for autism and other neurodevelopmental disorders in the Autism Spectrum Center and in the Neurogenetics clinic. As a physician-scientist at Harvard Medical School/Boston Children's Hospital, Dr. Mo uses high-throughput sequencing, computational analysis, and functional modeling of genomic variation to study the genetics of autism. Dr. Mo is also a patient advocate for families with rare diseases.

Publications

  1. Clinical and Neuropsychological Phenotyping of Individuals With Somatic Variants in Neurodevelopmental Disorders. Neurol Genet. 2025 Apr; 11(2):e200254. View Abstract

  2. Novel Phenotypes and Genotype-Phenotype Correlations in a Large Clinical Cohort of Patients With Kleefstra Syndrome. Clin Genet. 2025 Jun; 107(6):636-645. View Abstract

  3. Cell-type-specific effects of autism-associated 15q duplication syndrome in the human brain. Am J Hum Genet. 2024 Aug 08; 111(8):1544-1558. View Abstract

  4. Cell-type-specific effects of autism-associated chromosome 15q11.2-13.1 duplications in human brain. bioRxiv. 2024 May 22. View Abstract

  5. Exome Sequencing and the Identification of New Genes and Shared Mechanisms in Polymicrogyria. JAMA Neurol. 2023 09 01; 80(9):980-988. View Abstract

  6. The clinical and molecular spectrum of ZFYVE26-associated hereditary spastic paraplegia: SPG15. Brain. 2023 05 02; 146(5):2003-2015. View Abstract

  7. A recurrent de novo variant in NUSAP1 escapes nonsense-mediated decay and leads to microcephaly, epilepsy, and developmental delay. Clin Genet. 2023 07; 104(1):73-80. View Abstract

  8. TMEM161B regulates cerebral cortical gyration, Sonic Hedgehog signaling, and ciliary structure in the developing central nervous system. Proc Natl Acad Sci U S A. 2023 01 24; 120(4):e2209964120. View Abstract

  9. Blended Phenotype of Prader-Willi Syndrome and HSP-SPG11 Caused by Maternal Uniparental Isodisomy. Neurol Genet. 2022 Dec; 8(6):e200041. View Abstract

  10. Early-Onset and Severe Complex Hereditary Spastic Paraplegia Caused by De Novo Variants in SPAST. Mov Disord. 2022 12; 37(12):2440-2446. View Abstract

  11. Upper motor neuron signs and early onset gait abnormalities in young children with bi-allelic VWA1 variants. Am J Med Genet A. 2022 12; 188(12):3531-3534. View Abstract

  12. Neurodevelopmental profile of HIVEP2-related disorder. Dev Med Child Neurol. 2022 05; 64(5):654-661. View Abstract

  13. Child Neurology: Recurrent Brainstem Strokes and Aphthous Ulcers in a Child With Mutations in the ADA2 Gene. Neurology. 2021 Oct 04; 97(14):696-699. View Abstract

  14. Epigenomic landscapes of retinal rods and cones. Elife. 2016 Mar 07; 5:e11613. View Abstract

  15. Epigenomic Signatures of Neuronal Diversity in the Mammalian Brain. Neuron. 2015 Jun 17; 86(6):1369-84. View Abstract

  16. Cellular resolution maps of X chromosome inactivation: implications for neural development, function, and disease. Neuron. 2014 Jan 08; 81(1):103-19. View Abstract

  17. Age, CAG repeat length, and clinical progression in Huntington's disease. Mov Disord. 2012 Feb; 27(2):272-6. View Abstract

  18. Characterization of multiple spiral wave dynamics as a stochastic predator-prey system. Phys Rev E Stat Nonlin Soft Matter Phys. 2008 Aug; 78(2 Pt 1):021913. View Abstract
BESbswy